FunGen-xQTL Resources

Alzheimer's disease GWAS overview

The FunGen-xQTL flagship study uses summary statistics from large Alzheimer’s disease (AD) GWAS as the trait input for fine-mapping, TWAS and colocalization.

All summary statistics were harmonized to GRCh38 before downstream analysis. The APOE region (chr19:44.4 to 46.5 Mb) was analyzed separately because of its complex LD structure. The LD reference panel was built from 16,571 ADSP whole-genome sequenced samples of European ancestry.

Datasets

The study used twelve datasets from four AD meta-analyses: Bellenguez, Wightman, Kunkle and Jansen. They cover clinically diagnosed AD, proxy AD cases (people whose parent had dementia) and broader dementia phenotypes. Lambert et al. 2013 (IGAP stage 1) is cited as a historical reference and is not one of the twelve.

DatasetStudyPopulationN casesN controlsPhenotype definition
AD_Bellenguez_2022Bellenguez et al. 2022 Nat GenetEuropean111,326677,663Clinically diagnosed AD plus proxy AD and related dementia cases (UK Biobank family history); see the noproxy analysis for clinical cases only. Primary GWAS, used throughout
AD_Bellenguez_EADB_2022Bellenguez et al. 2022, EADB subsetEuropeann/an/an/a
AD_Bellenguez_EADI_2022Bellenguez et al. 2022, EADI subsetEuropeann/an/an/a
AD_Bellenguez_GRACE_2022Bellenguez et al. 2022, GRACE cohortEuropeann/an/an/a
AD_Bellenguez_main_2026EADB et al. 2026 (Nat. Genet. 58, 1214–1225), consensus meta-analysis, main analysisEuropeann/an/an/a
AD_Bellenguez_noproxy_2026EADB et al. 2026 (Nat. Genet. 58, 1214–1225), consensus meta-analysis, without proxy casesEuropeann/an/an/a
AD_Bellenguez_nobiobank_2026EADB et al. 2026 (Nat. Genet. 58, 1214–1225), consensus meta-analysis, without biobank cohortsEuropeann/an/an/a
AD_Wightman_Full_2021Wightman et al. 2021 Nat GenetEuropean90,3381,036,225AD and proxy-AD (UK Biobank)
AD_Wightman_Excluding23andMe_2021Wightman et al. 2021, without 23andMeEuropeann/an/aAD and proxy-AD (UK Biobank)
AD_Wightman_ExcludingUKBand23andME_2021Wightman et al. 2021, without UK Biobank and 23andMeEuropeann/an/an/a
AD_Kunkle_Stage1_2019Kunkle et al. 2019 Nat GenetEuropean21,98241,944Clinically confirmed late-onset AD (ADGC/IGAP)
AD_Jansen_2021Jansen et al. 2019 Nat GenetEuropeann/an/aAD and proxy-AD (UK Biobank), meta-analysis with IGAP

AD_Bellenguez_GRACE_2022 has fine-mapping models only; the fine-mapping top-loci folder has the other eleven datasets.

Quality control

Summary statistics passed a QC procedure built around SLALOM. Manual curation then compared single-effect regression with conditional regression outputs and removed suspicious or unstable loci. The November 2 release of the AD × xQTL integration summary contains 226 AD loci.

LD reference panel

PanelN samplesPopulationBuildAD Knowledge Portal ID
ADSP WGS16,571European ancestryGRCh38syn69670651, subfolder EUR/ (syn69670652)

Data access

ResourceDescriptionAD Knowledge Portal ID
ADSP LD reference (EUR)LD panel for fine-mapping and colocalizationsyn69670652
LDSC reference dataLD scores, munged GWAS, sLDSC annotationssyn69670653
LDSC munged GWASPre-munged AD GWAS summary statisticssyn69670656
AD GWAS fine-mapping modelsFine-mapping outputs per GWAS datasetsyn69670625
AD fine-mapping resultsFine-mapped loci and credible setssyn69865805

All resources are in the FunGen-xQTL staging folder, syn68872650.

Abbreviations

AbbreviationFull name
ADAlzheimer’s disease
GWASGenome-wide association study
ADSPAlzheimer’s Disease Sequencing Project
IGAPInternational Genomics of Alzheimer’s Project
ADGCAlzheimer’s Disease Genetics Consortium
LDLinkage disequilibrium
WGSWhole-genome sequencing
QCQuality control
sLDSCStratified linkage disequilibrium score regression